A detailed history of Ibex Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Ibex Wealth Advisors holds 23,503 shares of AMGN stock, worth $6.09 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
23,503
Previous 25,763 8.77%
Holding current value
$6.09 Million
Previous $8.05 Million 5.93%
% of portfolio
0.65%
Previous 1.27%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$309.38 - $337.38 $699,198 - $762,478
-2,260 Reduced 8.77%
23,503 $7.57 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $313,198 - $380,617
1,192 Added 4.85%
25,763 $8.05 Million
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $6.6 Million - $7.97 Million
24,547 Added 102279.17%
24,571 $6.45 Million
Q4 2023

Jan 29, 2024

SELL
$255.7 - $288.46 $6.32 Million - $7.13 Million
-24,718 Reduced 99.9%
24 $7.05 Million
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $112,386 - $139,530
-514 Reduced 2.04%
24,742 $6.65 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $154,666 - $188,512
685 Added 2.79%
25,256 $6.11 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $161,466 - $205,162
705 Added 2.95%
24,571 $6.45 Million
Q3 2022

Oct 31, 2022

BUY
$224.46 - $253.15 $1,571 - $1,772
7 Added 0.03%
23,866 $5.38 Million
Q2 2022

Aug 16, 2022

BUY
$230.71 - $256.74 $81,902 - $91,142
355 Added 1.51%
23,859 $5.81 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $513,968 - $568,584
2,344 Added 11.08%
23,504 $5.68 Million
Q4 2021

Feb 22, 2022

BUY
$198.88 - $227.6 $261,527 - $299,294
1,315 Added 6.63%
21,160 $4.76 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $45,425 - $53,221
214 Added 1.09%
19,845 $4.22 Million
Q2 2021

Aug 20, 2021

BUY
$233.58 - $259.14 $192,703 - $213,790
825 Added 4.39%
19,631 $4.79 Million
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $235,224 - $274,116
1,060 Added 5.97%
18,806 $4.68 Million
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $65,995 - $78,589
305 Added 1.75%
17,746 $4.08 Million
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $2,815 - $3,131
-12 Reduced 0.07%
17,441 $4.43 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $853,945 - $1.05 Million
-4,317 Reduced 19.83%
17,453 $4.12 Million
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $372,680 - $494,276
-2,045 Reduced 8.59%
21,770 $4.41 Million
Q4 2019

Jan 24, 2020

BUY
$189.21 - $243.2 $261,866 - $336,588
1,384 Added 6.17%
23,815 $5.74 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $1.48 Million - $1.77 Million
8,490 Added 60.9%
22,431 $4.34 Million
Q2 2019

Jul 30, 2019

BUY
$166.7 - $195.41 $454,757 - $533,078
2,728 Added 24.33%
13,941 $2.57 Million
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $2.03 Million - $2.29 Million
11,213 New
11,213 $2.13 Million
Q1 2018

Jun 13, 2018

SELL
$169.43 - $198.0 $2.64 Million - $3.09 Million
-15,598 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $83,044 - $92,786
492 Added 3.26%
15,598 $2.82 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $2.53 Million - $2.89 Million
15,106
15,106 $2.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ibex Wealth Advisors Portfolio

Follow Ibex Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Wealth Advisors with notifications on news.